Table 3.
Glu/gli ratio | Gliadins% | ω5-gliadins% | ω1,2-gliadins% | ω-gliadins% | α/β-gliadins% | γ-gliadins% | ||
---|---|---|---|---|---|---|---|---|
Field trial | G*E | 0.39ns | 0.77ns | 4.93** | 3.22* | 1.10ns | 0.39ns | 0.90ns |
Genotype | 3.25* | 5.25** | 0.84ns | 17.38*** | 11.53*** | 6.77** | 5.23** | |
Treatment | 33.63*** | 47.66*** | 81.96*** | 44.69*** | 29.39*** | 27.48*** | 33.44*** | |
Glasshouse experiment | G*E | 6.88* | 7.47** | 2.52ns | 1.42ns | 3.87* | 2.61ns | 6.64* |
Genotype | 7.98* | 9.93** | 0.07ns | 1.77ns | 0.85ns | 0.43ns | 45.45*** | |
Treatment | 26.25*** | 37.13*** | 23.86*** | 17.26*** | 26.75*** | 24.38*** | 18.79*** |
The SPSS univariate analysis of variance (UNIANOVA) in general linear model was used to calculate the F-values of the four genotypes (G), three sulfur treatments (E) and G×E on each gluten component. *P < 0.05, **P < 0.01, ***P < 0.001; nsnot significant; the number of biologically independent replicate (plot or pot) for each genotype under each sulfur treatment is 3. Under a fixed nitrogen application rate of 25 kg ha−1, the statistically significant impacts of sulfur treatments on the ratio of glutenin to gliadin (glu/gli ratio), the percentages of gliadins (gliadins%) and its each subtype (ω-gliadins%, α/β-gliadins% and γ-gliadins%) in the total gluten content were observed in both 2014 field trial and glasshouse experiment.